Inactief instrument

Andere talen Golden Sun Capital Inc Toronto S.E.

Aandelen

GSTh

CA38123A1093

slotkoers Toronto S.E. Andere beurzen
-	-

11/06	Voyageur Pharmaceuticals Ltd. en Rain Cage Carbon Inc. kondigen de opvolging aan van de eerste commerciële creatie van V@C60 Endohedral Fullerene	CI
28/05	Voyageur Pharmaceuticals Ltd haalt USD 1,9 miljoen verkoopcontract binnen voor SmoothXTM 2% Barium Contrast	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Voyageur Pharmaceuticals and Rain Cage Carbon Partner to Develop Advanced Radiology Contrast Agents	11/06
Voyageur Pharmaceuticals Ltd. and Rain Cage Carbon Inc. Announce Follow Up on the First Commercial Creation of V@C60 Endohedral Fullerene	11/06
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development	11/06
Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America	28/05
Voyageur Pharmaceuticals Ltd Secures USD 1.9 Million Sales Contract for SmoothXTM 2% Barium Contrast	28/05
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast	28/05
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024	26/04
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors	03/04
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options	26/03
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	26/03
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc	13/03
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development	13/03
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement	04/03
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement	04/03
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement	01/03
Voyageur Pharmaceuticals Ltd. announced that it has received CAD 0.4885 million in funding	01/03
Voyageur Pharmaceuticals Ltd. announced that it expects to receive CAD 0.8 million in funding	16/01
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors	21/12
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule	21/12
Voyageur Pharmaceuticals takes major step forward announcing international expansion	18/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Golden Sun Capital Inc Toronto S.E.

Aandelen

GSTh

CA38123A1093

Andere talen

Filters